1.Impact of Interleukin-10 Gene Polymorphisms on Survival in Patients with Colorectal Cancer.
Wen Chien TING ; Lu Min CHEN ; Li Chia HUANG ; Mann Jen HOUR ; Yu Hsuan LAN ; Hong Zin LEE ; Bang Jau YOU ; Ta Yuan CHANG ; Bo Ying BAO
Journal of Korean Medical Science 2013;28(9):1302-1306
Chronic inflammation is thought to be the leading cause of colorectal cancer, and interleukin-10 (IL10) has been identified as a potent immunomodulatory cytokine that regulates inflammatory responses in the gastrointestinal tract. Although several single nucleotide polymorphisms (SNPs) in IL10 have been associated with the risk of colorectal cancer, their prognostic significance has not been determined. Two hundred and eighty-two colorectal cancer patients were genotyped for two candidate cancer-associated SNPs in IL10. The associations of these SNPs with distant metastasis-free survival and overall survival were evaluated by Kaplan-Meier analysis and Cox regression model. The minor homozygote GG genotype of IL10 rs3021094 was significantly associated with a 3.30-fold higher risk of death compared with the TT+TG genotypes (P=0.011). The patients with IL10 rs3021094 GG genotype also had a poorer overall survival in Kaplan-Meier analysis (log-rank P=0.007) and in multivariate Cox regression model (P=0.044) adjusting for age, gender, carcinoembryonic antigen levels, tumor differentiation, stage, lymphovascular invasion, and perineural invasion. In conclusion, our results suggest that IL10 rs3021094 might be a valuable prognostic biomarker for colorectal cancer patients.
Aged
;
Alleles
;
Carcinoembryonic Antigen/blood
;
Cell Differentiation
;
Colorectal Neoplasms/*genetics/mortality/pathology
;
Female
;
Genotype
;
Homozygote
;
Humans
;
Interleukin-10/*genetics
;
Kaplan-Meier Estimate
;
Lymphatic Metastasis
;
Male
;
Middle Aged
;
Neoplasm Staging
;
*Polymorphism, Single Nucleotide
;
Regression Analysis
;
Tumor Markers, Biological/genetics
2.A Study on the Relationship Between Genotype and Phenotype in Korean Patients with Congenital Adrenogenital Syndrome Caused by 21-hydroxylase Deficiency.
Dong Kyu JIN ; Jung Sim KIM ; Seung Mi SONG ; Sung Joon PARK ; He Zin HWANG ; Hwa Young ON ; Phil Soo OH ; Si Whan KOH ; Mee Ryung UHM ; Dong Hwan LEE ; Jah Hoon SHIN ; Heon Seok HAN ; Hong Sik KIM ; Cheol Woo KO ; Han Wook YOO ; Jin Sung LEE ; Duk Hee KIM
Journal of Korean Society of Endocrinology 2000;15(2):237-247
BACKGROUND: Congenital adrenal hyperplasia (CAH) results from an inherited defect in enzymatic steps required to synthesize cortisol from cholesterol. 21-hydroxylase deficiency accounts for 95% cases of CAH. It appears that the frequency and the type of the responsible mutations differ according to the ethnic background and the type of mutation can predict the clinical outcomes such as salt losing type (SL), simple virilizing type (SV) and non-classic type (NC). METHODS: We have analyzed CYP21 genes in 55 Korean cases (110 chromosomes) of CAH by Southern blotting, PCR-dot hybridization and PCR amplification-created restriction site method. The patients include 43 cases of SL and 12 of SV. None of the NC was found. RESULTS: We found the mutations in 94% (103/110) of the examined chromosomes. A total of 10 types of mutations were discovered. The mutations include aberrant splicing of intron 2 (i2, 35%), CYP21 gene deletion (32%) and I172N (11%) in order. When the relationship between the clinical types and genotypes were correlated, most of the SL patients have either i2 (42%) or CYP21 gene deletion (41%), while SV patients have I172N (33%) or P30L (21%). The parents' mutation was investigated in 20 cases. In 4 families, one of the parents was not the obligatory heterozygote carrier i.e. did not have a mutation. The results suggest the high incidence of de novo mutation. CONCLUSION: We have identified the frequency of mutations of the CYP21 in Korean AGS patients. Our results shows that the clinical type of AGS can be predicted from the genotypes of CYP21. Also the high incidence of de novo mutation of CYP21 confirmed the genetic instability of major histocompatibility III region where the CYP21 is located.
Adrenal Hyperplasia, Congenital
;
Adrenogenital Syndrome*
;
Blotting, Southern
;
Cholesterol
;
Gene Deletion
;
Genotype*
;
Heterozygote
;
Histocompatibility
;
Humans
;
Hydrocortisone
;
Incidence
;
Introns
;
Parents
;
Phenotype*
;
Polymerase Chain Reaction
;
Steroid 21-Hydroxylase*